Publication not explained
Read the Original
This page is a summary of: A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients, Therapeutics and Clinical Risk Management, September 2018, Dove Medical Press, DOI: 10.2147/tcrm.s174864.
You can read the full text:
Be the first to contribute to this page